Quick Answer
Vicapsys Life Sciences, Inc. reported Diluted EPS of $0.03 per share (loss) for fiscal year 2023.
Vicapsys Life Sciences, Inc. Diluted EPS — Annual History
| Fiscal Year | Diluted EPS | YoY Change |
|---|---|---|
| 2023 | -$0.03 | +0.0% |
| 2022 | -$0.03 | — |
Quarterly Diluted EPS
| Quarter Ending | Diluted EPS | YoY | QoQ |
|---|---|---|---|
| September 30, 2024 | -$0.01 | +0.0% | +0.0% |
| June 30, 2024 | -$0.01 | — | +0.0% |
| March 31, 2024 | -$0.01 | +0.0% | +0.0% |
| September 30, 2023 | -$0.01 | — | — |
| June 30, 2023 | $0.00 | +100.0% | +100.0% |
| March 31, 2023 | -$0.01 | +0.0% | — |
| September 30, 2022 | $0.00 | — | +100.0% |
| June 30, 2022 | -$0.01 | — | +0.0% |
- Vicapsys Life Sciences, Inc. showed an increase of +0.0% in Diluted EPS compared to the prior fiscal year.
- Over the 2022–2023 period, Vicapsys Life Sciences, Inc.’s diluted eps has grown by 0.0% (from $0.03 per share (loss) to $0.03 per share (loss)).
- The most recent figure is from Vicapsys Life Sciences, Inc.’s fiscal year 2023 report (Form 10-K), filed with the SEC on October 21, 2024.
- All figures are sourced from SEC EDGAR XBRL filings, last verified June 17, 2026.
Last verified: